On September 13, 2022, the European Commission granted authorisation to 4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO) to be used as a surfactant within a lubricant used in the manufacture of pharmaceutical drug products till January 04, 2030.